Barry McGuinness

Barry brings a wealth of knowledge from 12 years’ experience in the biotech sector of co-ordination of science, technology and commercial activities across the company’s R&D portfolio.

Barry was a co-founder at IOmet Pharma, where he served as Head of Scientific Operations. He oversaw a range of scientific programmes and was responsible for planning, monitoring and executing pre-clinical and clinical budgets and operations. He obtained his PhD in biochemistry from the University of Oxford in 2008.